American Society of Addiciton Medicine

Recent and Past Issues

  • ASAM Weekly for January 31, 2023

    A patient recently said to me, “At this point in my life, recovery is not only how I live, it’s who I am.” Although I realize – and have helped him understand – that recurrences can occur in the course of the chronic disease that is addiction, I was able to celebrate with him that he is now “right where he needs to be.”
    Full story
  • ASAM Weekly for January 24, 2023

    According to results from the 2021 National Survey on Drug Use and Health, nearly 1 in 3 adults in America had either a substance use disorder (SUD) or any mental illness (AMI) in the past year, almost half of all young adults had either a SUD or AMI, and for many with either (SUD or AMI) the COVID pandemic was a global stressor (NSDUH). Not often captured by NSDUH surveys, incarcerated individuals represent a broad population at high risk for opioid use disorder (OUD) and opioid-overdose deaths.
    Full story
  • ASAM Weekly for January 17, 2023

    Pain and addiction have a close relationship. For example, research has shown that three days of opioids prescribed for acute postoperative pain can increase the chances of chronic opioid use.
    Full story
  • ASAM Weekly for December 20, 2022

    Recent years in addiction medicine have been transformative, and this year was exceptional. The opioid crisis and the COVID pandemic, being front-of-mind for many, created a sense of awareness in Washington D.C. that we must continue to capitolize on (spelling pun intended) (NPR, NBC).
    Full story
  • ASAM Weekly for January 10, 2023

    Defining and diagnosing addiction has evolved over the years with cravings becoming a core component in the conceptualization. As we move forward, machine learning is enabling scientists to identify stable brain patterns that can function as a neuromarker for cravings (food and drugs) and potentially be used in diagnosis and treatment response.
    Full story
  • ASAM Weekly for January 3, 2023

    To borrow from a conceptualization about human behavior — a good way to predict future news is to look at past news. This week we present to you the most read news publications of 2022.
    Full story
  • ASAM Weekly for December 27, 2022

    Treatments for alcohol withdrawal continue to resonate, particularly updates with benzodiazepine-sparing protocols (JAMA Network Open). Research is identifying cannabis as a possible risk factor for dementia (American Journal of Psychiatry) and concern continues to grow around psychotic disorders and potency (The Lancet Psychiatry).
    Full story
  • ASAM Weekly for December 20, 2022

    Full story
  • ASAM Weekly for December 13, 2022

    Full story
  • ASAM Weekly for December 6, 2022

    Full story

This Week in Addiction Medicine Podcast

A weekly audio summary and podcast of the ASAM Weekly



The ASAM Weekly

Editors & Staff

Editor-in-Chief: Nicholas Athanasiou, MD, MBA, DFASAM
Emeritus Editor: William Haning, MD, DFAPA, DFASAM
Publications Chair: Nicholas Athanasiou, MD, MBA, DFASAM
Co-Editors: Brandon Aden, MD, Debra R. Newman, PA-C, MSPAS, MPH, Jack Woodside, MD, John A. Fromson, MD

Please direct customer service inquiries and comments to: ASAMWeekly@ASAM.org

The ASAM Weekly

Advertiser Services & Sales

Ad space is limited and available on a first-paid, first-published basis. To assure your ad will run in the specific issue you select, Insertion Orders must be signed by an authorized person in your organization and accepted by your customer service representative before taking the advertising units out of the active sales inventory. Payment must be received prior to the run date for an ad. Insertion Orders provide several options for payment in full including all major credit cards or check. Pre-approved billing must be arranged directly by an ASAM representative.

To learn more about advertising opportunities
Contact: Bob Davis at Bdavis@ASAM.org